IMHA Immunosuppressive Therapy Interactive Guide

Canine IMHA Immunosuppressive Therapy

An interactive executive clinical summary derived from the 2019 ACVIM Consensus Guidelines. Navigate protocols, compare single vs. dual therapy, and utilize the interactive decision support tool below.

1. The Core Rules of Immunosuppression

This section establishes the foundational pharmacological agents used in IMHA treatment. It outlines the primary and secondary drug choices, providing the fundamental rules that govern all subsequent clinical decisions in this application.

💊

Glucocorticoids (The Foundation)

Prednisone or Prednisolone are the absolute first-line foundation of therapy.

  • ✓ Rapid onset of action (hours).
  • ✓ Immediately down-regulates Fc-receptor expression on macrophages.
  • ✓ Halts destruction of antibody-coated red blood cells in the spleen and liver.
🧬

Mycophenolate Mofetil (The Secondary)

MMF is a secondary agent that targets T and B-lymphocyte proliferation.

  • ⚠ Delayed onset of action (takes several days to reach full clinical efficacy).
  • ⚠ Can never be used as monotherapy to manage acute hemolytic crises.

2. Clinical Decision Support Tool

Interact with the criteria below to determine the appropriate therapy protocol based on the patient's presentation. This interactive checklist synthesizes the ACVIM conditions for Day 1 Dual Therapy, Sequential Therapy, and Rescue Therapy into a dynamic recommendation engine.

Select Presenting Clinical Signs:

High-Risk Indicators (Day 1)

Stable Presentation (Day 1)

Post-Treatment Monitoring (Days 5-7+)

ACVIM Recommendation Output
🩺

Select clinical signs from the panel to generate protocol recommendations.

3. Pharmacological Onset Comparison

This interactive chart visualizes the critical difference in the onset of clinical efficacy between the primary and secondary agents. Understanding this timeline is crucial for managing acute hemolytic crises, demonstrating why MMF cannot be used as monotherapy initially.

Hover over the bars to view detailed onset windows and clinical mechanisms.

4. Absolute Contraindications

This section highlights the most critical safety warning in the ACVIM guidelines regarding polypharmacy in IMHA management.

🛑

The "Three-Drug" Absolute Red Flag

Veterinarians must AVOID prescribing three or more immunosuppressive drugs concurrently.

Example to Avoid: Prednisone + Mycophenolate + Cyclosporine
Multi-drug cocktails do not increase survival rates. Instead, they cause profound, catastrophic collapse of the immune system, leading directly to fatal opportunistic infections, sepsis, or severe bone marrow suppression.
Interactive guide based on the 2019 ACVIM Consensus Guidelines for Canine IMHA.